Anthony Philippakis
Co-founder & CEO
Arboretum LifeSciences
AI and genetic testing to bring precision medicine to common diseases
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Arboretum LifeSciences is a Cambridge, Massachusetts molecular information company founded by leaders from the Broad Institute's Data Sciences Platform. It provides genetic testing for health-system precision medicine programs and uses AI and clinical data to help drugmakers find genetically defined patient populations and recruit genomically profiled patients for trials in diseases like coronary artery disease, diabetes and neurodegeneration. CEO and co-founder Anthony Philippakis announced a $30M Series A in October 2026 led by F-Prime, GV, .406 Ventures, Hims & Hers and Amgen.
- Website
- arboretum.bio
- Stage
- series-a
- Location
- Cambridge, MA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Arboretum Clinical — Genetic tests for inherited cancer, heart disease and other risks · Service